Guolin Li

3.3k total citations
39 papers, 2.1k citations indexed

About

Guolin Li is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Guolin Li has authored 39 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Guolin Li's work include Pancreatic and Hepatic Oncology Research (11 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Guolin Li is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Guolin Li collaborates with scholars based in China, United States and Hong Kong. Guolin Li's co-authors include Shangyou Zheng, Qing Lin, Lusheng Wei, Huilin Ye, Quanbo Zhou, Zhihua Li, Min Jun, Lihong Lv, Yimin Liu and Yihui Chen and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Organic Chemistry.

In The Last Decade

Guolin Li

37 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guolin Li China 23 1.2k 855 507 392 285 39 2.1k
Xipeng Wang China 28 1.6k 1.3× 1.1k 1.2× 480 0.9× 826 2.1× 210 0.7× 66 2.8k
Xiao Yuan China 21 1.6k 1.3× 1.1k 1.2× 497 1.0× 484 1.2× 314 1.1× 75 2.6k
Kaitai Zhang China 24 791 0.7× 465 0.5× 611 1.2× 294 0.8× 495 1.7× 89 2.2k
Zongyou Chen China 27 991 0.8× 684 0.8× 438 0.9× 384 1.0× 155 0.5× 97 2.1k
Aiping Luo China 29 1.8k 1.5× 998 1.2× 598 1.2× 296 0.8× 159 0.6× 66 2.5k
Chun‐Wei Peng China 29 1.0k 0.9× 525 0.6× 660 1.3× 230 0.6× 396 1.4× 64 2.3k
Qian Xie China 27 1.0k 0.9× 412 0.5× 441 0.9× 292 0.7× 276 1.0× 79 2.3k
Renbing Jia China 35 2.5k 2.1× 1.4k 1.7× 950 1.9× 558 1.4× 346 1.2× 174 4.4k
Partha Ray United States 20 1.5k 1.2× 381 0.4× 387 0.8× 406 1.0× 222 0.8× 49 2.3k
Yu Yao China 24 743 0.6× 326 0.4× 378 0.7× 207 0.5× 430 1.5× 62 1.6k

Countries citing papers authored by Guolin Li

Since Specialization
Citations

This map shows the geographic impact of Guolin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guolin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guolin Li more than expected).

Fields of papers citing papers by Guolin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guolin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guolin Li. The network helps show where Guolin Li may publish in the future.

Co-authorship network of co-authors of Guolin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guolin Li. A scholar is included among the top collaborators of Guolin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guolin Li. Guolin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Qing, Guolin Li, Qing Tian, et al.. (2024). Extracellular vesicle–packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models. Science Translational Medicine. 16(756). eadi0178–eadi0178. 32 indexed citations
2.
Chen, Qin, Guolin Li, Jiandong Yu, et al.. (2023). The neutrophil-to-lymphocyte ratio and lactate dehydrogenase combined in predicting liver metastasis and prognosis of colorectal cancer. Frontiers in Medicine. 10. 1205897–1205897. 8 indexed citations
3.
Li, Guolin, Linna Gu, Fulei Zhao, et al.. (2023). WFDC12-overexpressing contributes to the development of atopic dermatitis via accelerating ALOX12/15 metabolism and PAF accumulation. Cell Death and Disease. 14(3). 185–185. 10 indexed citations
4.
Hu, Chonghui, Renpeng Xia, Xiang Zhang, et al.. (2022). circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis. Molecular Cancer. 21(1). 24–24. 107 indexed citations
5.
Yu, Jiadong, Qixiang Zhao, Xiaoyan Wang, et al.. (2022). Pathogenesis, multi-omics research, and clinical treatment of psoriasis. Journal of Autoimmunity. 133. 102916–102916. 58 indexed citations
6.
7.
Wei, Jinxing, Lihong Lv, Qingfang Han, et al.. (2020). Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma. Cell Communication and Signaling. 18(1). 46–46. 78 indexed citations
8.
Luo, Min, et al.. (2020). Application of a surgical nursing cooperation program in laparoscopic pancreaticoduodenectomy. Gland Surgery. 9(5). 1530–1534. 1 indexed citations
9.
Zhu, Yinxin, Chi Han Li, Guolin Li, et al.. (2020). LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma. Cellular and Molecular Gastroenterology and Hepatology. 10(4). 811–828. 24 indexed citations
10.
Zhou, Quanbo, Zhiguo Li, Huilin Ye, et al.. (2019). Intraoperative Radiotherapy for Borderline Resectable Pancreatic Cancer: A Retrospective Analysis. 4(1). 1 indexed citations
11.
Han, Qingfang, Lihong Lv, Jinxing Wei, et al.. (2019). Vps4A mediates the localization and exosome release of β-catenin to inhibit epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Letters. 457. 47–59. 50 indexed citations
12.
13.
Wei, Lusheng, Huilin Ye, Guolin Li, et al.. (2018). Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer. Cell Death and Disease. 9(11). 1065–1065. 134 indexed citations
14.
Ye, Huilin, Quanbo Zhou, Shangyou Zheng, et al.. (2018). Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma. Cell Death and Disease. 9(5). 453–453. 175 indexed citations
15.
Cheng, Di, Junge Deng, Bin Zhang, et al.. (2018). LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation. EBioMedicine. 36. 159–170. 133 indexed citations
16.
Ye, Huilin, Quanbo Zhou, Shangyou Zheng, et al.. (2018). FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. Cell Death and Disease. 9(2). 34–34. 50 indexed citations
17.
Cao, Jun, Guolin Li, Jinxing Wei, et al.. (2018). Laparoscopic duodenum-preserving total pancreatic head resection: a novel surgical approach for benign or low-grade malignant tumors. Surgical Endoscopy. 33(2). 633–638. 24 indexed citations
18.
Lv, Lihong, Yun-Le Wan, Yan Lin, et al.. (2012). Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro. Journal of Biological Chemistry. 287(19). 15874–15885. 381 indexed citations
19.
Sun, Tianjia, et al.. (2012). A Two-Hop Wireless Power Transfer System With an Efficiency-Enhanced Power Receiver for Motion-Free Capsule Endoscopy Inspection. IEEE Transactions on Biomedical Engineering. 59(11). 3247–3254. 120 indexed citations
20.
Yu, Jiandong, et al.. (2011). Donor liver natural killer cells alleviate liver allograft acute rejection in rats. Hepatobiliary & pancreatic diseases international. 10(4). 386–392. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xipeng Wang Breakdown of academic impact, for papers by Xiao Yuan Breakdown of academic impact, for papers by Kaitai Zhang Breakdown of academic impact, for papers by Zongyou Chen Breakdown of academic impact, for papers by Aiping Luo Breakdown of academic impact, for papers by Chun‐Wei Peng Breakdown of academic impact, for papers by Qian Xie Breakdown of academic impact, for papers by Renbing Jia Breakdown of academic impact, for papers by Partha Ray Breakdown of academic impact, for papers by Yu Yao
Rankless by CCL
2026